Menlo Park, CA, United States of America

Andreas G Moraitis

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Glucocorticoid Receptor Modulators. Top assignees: Corcept Therapeutics Incorporated, Corcept Therapeutics Incorpoarted. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas G Moraitis. Retrieved from https://idiyas.com/inventor/andreas-g-moraitis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 1.2

ph-index = 5

Forward Citations = 108(Granted Patents)

Location History:

Menlo Park, CA (US) (2017 - 2024)
Sunny Isles Beach, FL (US) (2021 - 2024)

Company Filing History:

33 out of 138

Corcept Therapeutics Incorporated

patents

1 out of 1

Corcept Therapeutics Incorpoarted

patent

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Cushing's Syndrome

Pituitary Tumors

Neuroepithelial Tumors

Glucocorticoid Receptor Modulators

ACTH

Hypercoagulopathy

Cancer Treatment

Therapeutic Uses

Glucocorticoid Receptor Antagonists

Somatostatin-Receptor Positive Tumors

Differential Diagnosis

Adrenal Insufficiency

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691127 - Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency (2026-07-28),

2. 12625150 - Treatment of, and differential diagnosis between, ACTH-dependent Cushing's syndrome and ACTH-independent Cushing's syndrome (2026-05-12),

3. 12336985 - Methods for shrinking pituitary tumors (2025-06-24),

4. 12290551 - Methods for imaging and treatment of somatostatin-receptor positive tumors (2025-05-06),

5. 12263169 - Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators (2025-04-01),

6. 12102642 - Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators (2024-10-01),

7. 12097192 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2024-09-24),

8. 12005055 - Methods for shrinking pituitary tumors (2024-06-11),

9. 11890289 - Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency (2024-02-06),

10. 11793810 - Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators (2023-10-24),

11. 11744837 - Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients (2023-09-05),

12. 11684612 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2023-06-27),

13. 11590113 - Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (2023-02-28),

14. 11524013 - Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators (2022-12-13),

15. 11389432 - Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent (2022-07-19),

Title: Andreas G Moraitis: Pioneering Inventor from Menlo Park

Introduction: Andreas G Moraitis is a distinguished inventor based in Menlo Park, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Andreas G Moraitis holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Moraitis has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Andreas G Moraitis has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Andreas G Moraitis stands as a visionary inventor whose work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.